Stevanato Group S.p.A. Company Profile
NYSE: STVNHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 9, 12:53 PM ET
Stevanato Group S.p.A. at a glance
Stevanato Group S.p.A. (NYSE: STVN) is a Medical/Dental Instruments company in the Health Care sector headquartered in Piombino Dese, PD, Italy. Stevanato Group S.p.A. is led by Mr. Franco Stevanato and employs about 6,010 people. The company's shares have traded publicly since 2021.
At a market capitalization of $5.31 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001849853, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Stevanato Group S.p.A. do?
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Business description based on the company's public filings.
Company information
- Legal name
- Stevanato Group S.p.A.
- Ticker
- NYSE: STVN
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Franco Stevanato
- Employees
- 6,010
- Headquarters
- Via Molinella 17, Piombino Dese, PD, Italy
- Phone
- 39 04 99 31 811
- Website
- stevanatogroup.com
- IPO year
- 2021
- Market cap
- $5.31B
- SEC CIK
- 0001849853
Companies similar to Stevanato Group S.p.A.
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TFXTeleflex Incorporated | 124.19 | -0.00% | $5.26B | vs STVN |
| MMSIMerit Medical Systems Inc. | 87.39 | +2.51% | $5.22B | vs STVN |
| HAEHaemonetics Corporation | 118.71 | -0.64% | $5.40B | vs STVN |
| MMEDMiniMed Group Inc. | 19.62 | -0.91% | $5.52B | vs STVN |
| HTFLHeartflow Inc. | 49.48 | +3.88% | $4.30B | vs STVN |
| ICUIICU Medical Inc. | 158.94 | +1.12% | $3.97B | vs STVN |
| PLSEPulse Biosciences Inc | 52.00 | +4.04% | $3.71B | vs STVN |
| NVSTEnvista Holdings Corporation | 22.82 | +0.44% | $3.67B | vs STVN |